Israel Englander Biomea Fusion, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 120,000 shares of BMEA stock, worth $702,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,000
Previous 50,000
140.0%
Holding current value
$702,000
Previous $225,000
438.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMEA
# of Institutions
104Shares Held
17.8MCall Options Held
1.68MPut Options Held
410K-
Cormorant Asset Management, LP Boston, MA3.57MShares$20.9 Million2.53% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$13.7 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$12.3 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$8.18 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA900KShares$5.27 Million0.02% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $171M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...